Hy. Xiang et al., FINANCING CHANGES OF SCHISTOSOMIASIS CONTROL PROGRAMS IN CHINA 1980-1995 - A CASE-STUDY IN SONGZI COUNTY, TM & IH. Tropical medicine & international health, 3(6), 1998, pp. 454-461
To assess the financing changes of schistosomiasis control programmes
in China and estimate the impact of these changes on patients' treatme
nt-seeking behaviour and control of schistosomiasis, a survey was cond
ucted in five schistosomiasis-endemic areas of the lake regions, Hubei
province, in 1996. This paper reports financing changes and their imp
act on the incidence and prevalence of schistosomiasis from one of the
five areas as a case study By examining the surveillance and financia
l data from 1980 to 1995, and through focus group discussions we found
that the schistosomiasis control programmes in People's Republic of C
hina have gone through dramatic financing changes from 1980 to 1995, w
hen the transitions of China's social, economic, and political systems
happened. The proportions of funding to schistosomiasis control progr
ammes from high level governmental agencies, county budgets, and servi
ces revenue changed from 60%, 23%, and 17%, respectively, in 1980-1987
to 0.7%, 22.3%, and 72% in 1995. The percentageages of expenditure of
schistosomiasis control activities, salaries and bonuses, and other a
ctivities unrelated to schistosomiasis control, were 53.5%, 14.4, and
17.2% in 1980, These percentageages changed to 7.7%, 33.3%, and 53.3%,
respectively, in 1995. The preponderant role of the state in organizi
ng, financing, and delivery of the services was replaced with the new
system which is more influenced by the market economy. The incidence a
nd the prevalence of schistosomiasis in the study area have increased
lear by year from 1980 to 1990. although there has been a tendency to
decrease after 1991 but not to the low pre1980 levels. The collapse of
the community-based medical system in rural areas and the dramatic fi
nancing changes of schistosomiasis control programmes have created maj
or difficulties For schistosomiasis control in China.